Medpace Holdings (MEDP) Share-based Compensation (2015 - 2026)

Medpace Holdings (MEDP) has reported Share-based Compensation for 12 consecutive years, with $4.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Share-based Compensation fell 26.94% year-over-year to $4.3 million; the trailing twelve-month figure through Jun 2026 stood at $21.2 million (down 47.58% YoY), and the FY2025 full-year result was $34.8 million, up 36.34% from the prior year.
• Share-based Compensation declined to $4.3 million in Q2 2026 per MEDP's latest filing, from $4.9 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $16.9 million in Q1 2025 and bottomed at $3.6 million in Q2 2024.
• Historically, Share-based Compensation has averaged $6.2 million across 5 years, with a median of $5.5 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Share-based Compensation surged 291.93% in 2025, then slumped 70.89% in 2026.
• Over 5 years, Share-based Compensation stood at $5.6 million in 2022, then declined by 7.65% to $5.2 million in 2023, then increased by 14.02% to $5.9 million in 2024, then decreased by 4.57% to $5.6 million in 2025, then slipped by 22.63% to $4.3 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $4.3 million, $4.9 million, and $5.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.